Who is sponsoring NCT04597021?

NCT04597021 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT04597021?

Interventions in NCT04597021: use of a wiresless US transducer.

What condition does NCT04597021 study?

NCT04597021 studies Wireless Ultrasound, Central Venous Catheter, Congenital Heart Disease in Children.

Is NCT04597021 still recruiting?

NCT04597021 is currently completed. Last updated 23 October 2020.

Last reviewed 2020-10-23 · How we verify

NCT04597021

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Wireless US-guided CVC Placement in Infants

Completed Last updated 23 October 2020

What this trial tests

trial testing use of a wiresless US transducer in Wireless Ultrasound in 30 participants. Completed in 30 January 2019.

Timeline

1 August 2018

Primary endpoint
30 January 2019

30 January 2019

Quick facts

Lead sponsor	Medical University of Vienna
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 August 2018
Primary completion	30 January 2019
Estimated completion	30 January 2019
Sites	1 location across Austria

Drugs / interventions tested

use of a wiresless US transducer

Conditions studied

Wireless Ultrasound — all drugs for Wireless Ultrasound →
Central Venous Catheter — all drugs for Central Venous Catheter →
Congenital Heart Disease in Children — all drugs for Congenital Heart Disease in Children →

Sponsor

Medical University of Vienna

Who can join

Under 2, any sex, with Wireless Ultrasound or Central Venous Catheter. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Neonates and small infants with congenital cardiac disease undergoing cardiac surgery represent major challenges facing pediatric anesthesia and perioperative medicine. Aims: We here aimed to investigate the success rates in performing ultrasound guided central venous catheter insertion (CVC) in neonates and small infants undergoing cardiac surgery, and to evaluate the practicability and feasibility of thereby using a novel wireless ultrasound transducer (WUST). Methods: Thirty neonates and small infants with a maximum body weight of 10 kg and need for CVC before cardiac surgery were included in this observational trial and were subdivided into two groups according to their weight: \< 5 kg and ≥5 kg. Cannulation success, failure rate, essential procedure related time periods, and complications were recorded and the clinical utility of the WUST was assessed by a 5-point Likert scale.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Performing central venous catheters in neonates and small infants undergoing cardiac surgery using a wireless transducer for ultrasound guidance: a prospective, observational pilot study.
Schiefer J, Lichtenegger P, Zimpfer D, Hutschala D, et al · · 2021 · cited 7× · PMID 34389009 · DOI 10.1186/s12887-021-02822-w

Verify or expand the search:

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04597021 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 23 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04597021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing